Showing results (2121-2130 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapyMonique de Visser, Suzanne M Verwijnen, Marion de JongCancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumorsWen Ping Li, Laura A Meyer, David A Capretto, et al.Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodiesEneida R Nemecek, Damian J Green, Darrell R Fisher, et al.Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cellsPatric M Schiltz, Robert O Dillman, Catharina M Korse, et al.Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neckDavid Loose, Alberto Signore, Elena Bonanno, et al.Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Surface expression of gpA33 is dependent on culture density and cell-cycle phase and is regulated by intracellular traffic rather than gene transcriptionDietmar Frey, Vania Coelho, Ulf Petrausch, et al.Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Cancer stem cell targeting using the alpha-particle emitter, 213Bi: mathematical modeling and feasibility analysisGeorge Sgouros, Hong SongCancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Intracavitary radioimmunotherapy to treat solid tumorsFrits Aarts, Robert P Bleichrodt, Wim J G Oyen, et al.Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Comparison of [177Lu-DOTA0,Tyr3]-octreotate and [177Lu-DOTA0,Tyr3]-octreotide for receptor-mediated radiation therapy of the xenografted human midgut carcinoid tumor GOT1Christina Swärd, Peter Bernhardt, Viktor Johanson, et al.Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
Dendritic cells expressing a combined PADRE/MUC4-derived polyepitope DNA vaccine induce multiple cytotoxic T-cell responsesJishu Wei, Wentao Gao, Junli Wu, et al.Pageof 224